Ohio State Navbar

Sign In

RSS Feed Regenerative Medicine News


First Patient Treated In Cytori’s U.S. Cell Therapy Heart Failure Trial  

 

 

First Patient Treated In Cytori’s U.S. Cell Therapy Heart Failure Trial 

October 11, 2012 - (Cytori) -"Cytori Therapeutics announced the initiation of the FDA approved ATHENA clinical trial to investigate Cytori’s cell therapy in patients who suffer from a severe form of refractory (untreatable) heart failure due to chronic myocardial ischemia. Cytori’s cell therapy is based on a patient’s own adipose-derived stem and regenerative cells (ADRCs) processed by the Company’s proprietary Celution® System technology, making this the first FDA approved trial in the U.S. to evaluate ADRCs for cardiovascular disease."  Read Full Article

 

Posted on 18-Oct-12 by Gallerno, Jacob
Tags: Science and Industry News
 
Trackback Url  |  Link to this post | Bookmark this post with: